Abstract
Antibodies specific for fibronectin were utilized to determine the sites of localization in the liver during development. The livers of fetal rats from each of gestation days 11‐19, and from days 1 and 8 postpartum, were studied by fluorescence microscopy. Fibronectin was localized predominatly in megakaryocytes and megakaryocyte precursors, and to a lesser extent in the extracellular matrix surrounding blood vessels and between hepatocytes and sinusoids. The cytoplasm of megakaryocytes and their precursors displayed bright fluorescence but their nuclei were negative for fibronectin. Hepatocytes had negative or faint fluorescence. Megakaryocytes were present in the liver from day 12, and were numerous from day 13 through most of the rest of gestation. The relative numbers of megakaryocytes decreased in later gestation; at 8 days postpartum only a few were observed per section. Hepatic megakaryocytes appeared before megakaryocytes were established in spleen and bone marrow. The early and persistent high levels of fibronectin in hepatic megakaryocytes, in the absence of comparable localization within hepatocytes, leads us to the hypothesis that megakaryocytes are important in establishing circulating fibronectin levels in the fetus. Similarly, bone marrow megakaryocytes may contribute to circulating fibronectin in the adult.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 90-94 |
| Number of pages | 5 |
| Journal | The Anatomical Record |
| Volume | 223 |
| Issue number | 1 |
| DOIs | |
| State | Published - Jan 1 1989 |
Fingerprint
ASJC Scopus subject areas
- Anatomy
Cite this
Localization of fibronectin in megakaryocytes of fetal liver. / Bockman, Dale E.; Gulati, Adarsh K.
In: The Anatomical Record, Vol. 223, No. 1, 01.01.1989, p. 90-94.Research output: Contribution to journal › Article
}
TY - JOUR
T1 - Localization of fibronectin in megakaryocytes of fetal liver
AU - Bockman, Dale E.
AU - Gulati, Adarsh K
PY - 1989/1/1
Y1 - 1989/1/1
N2 - Antibodies specific for fibronectin were utilized to determine the sites of localization in the liver during development. The livers of fetal rats from each of gestation days 11‐19, and from days 1 and 8 postpartum, were studied by fluorescence microscopy. Fibronectin was localized predominatly in megakaryocytes and megakaryocyte precursors, and to a lesser extent in the extracellular matrix surrounding blood vessels and between hepatocytes and sinusoids. The cytoplasm of megakaryocytes and their precursors displayed bright fluorescence but their nuclei were negative for fibronectin. Hepatocytes had negative or faint fluorescence. Megakaryocytes were present in the liver from day 12, and were numerous from day 13 through most of the rest of gestation. The relative numbers of megakaryocytes decreased in later gestation; at 8 days postpartum only a few were observed per section. Hepatic megakaryocytes appeared before megakaryocytes were established in spleen and bone marrow. The early and persistent high levels of fibronectin in hepatic megakaryocytes, in the absence of comparable localization within hepatocytes, leads us to the hypothesis that megakaryocytes are important in establishing circulating fibronectin levels in the fetus. Similarly, bone marrow megakaryocytes may contribute to circulating fibronectin in the adult.
AB - Antibodies specific for fibronectin were utilized to determine the sites of localization in the liver during development. The livers of fetal rats from each of gestation days 11‐19, and from days 1 and 8 postpartum, were studied by fluorescence microscopy. Fibronectin was localized predominatly in megakaryocytes and megakaryocyte precursors, and to a lesser extent in the extracellular matrix surrounding blood vessels and between hepatocytes and sinusoids. The cytoplasm of megakaryocytes and their precursors displayed bright fluorescence but their nuclei were negative for fibronectin. Hepatocytes had negative or faint fluorescence. Megakaryocytes were present in the liver from day 12, and were numerous from day 13 through most of the rest of gestation. The relative numbers of megakaryocytes decreased in later gestation; at 8 days postpartum only a few were observed per section. Hepatic megakaryocytes appeared before megakaryocytes were established in spleen and bone marrow. The early and persistent high levels of fibronectin in hepatic megakaryocytes, in the absence of comparable localization within hepatocytes, leads us to the hypothesis that megakaryocytes are important in establishing circulating fibronectin levels in the fetus. Similarly, bone marrow megakaryocytes may contribute to circulating fibronectin in the adult.
UR - http://www.scopus.com/inward/record.url?scp=0024575072&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=0024575072&partnerID=8YFLogxK
U2 - 10.1002/ar.1092230113
DO - 10.1002/ar.1092230113
M3 - Article
C2 - 2916757
AN - SCOPUS:0024575072
VL - 223
SP - 90
EP - 94
JO - Anatomical Record
JF - Anatomical Record
SN - 0003-276X
IS - 1
ER -